Abstract
Background: Premature mortality from non-communicable diseases (NCDs), particularly cancer and cardiovascular disease (CVD), threatens population health, workforce participation, and economic sustainability across Europe. However, comparative evidence on their productivity costs across European regions remains limited. Objective: To estimate and compare the productivity costs of premature cancer and CVD mortality among working-age populations across Europe and assess regional inequalities. Methods: A quantitative, retrospective, cross-sectional comparative modelling study was conducted using secondary data from 30 European countries. Mortality data for adults aged 15–64 years were obtained from the World Health Organization Mortality Database, and labour market and economic data from Eurostat. A lifecycle simulation model incorporating age-specific earnings, employment rates, and labour force participation was developed to estimate productivity losses associated with premature mortality. Productivity costs were expressed in 2021 Euros and as a proportion of Gross Domestic Product (GDP). Results: Premature mortality from cancer and CVD generated productivity losses of €195.7 billion, equivalent to 1.24% of European GDP. Cancer accounted for €122.2 billion (62.5%) and CVD for €73.5 billion (37.5%). Productivity losses per death were slightly higher for CVD (€219,848; 95% CI 165,241–270,247) than cancer (€217,744; 95% CI 166,554–273,144). Central and Eastern Europe experienced the highest relative economic burden. Conclusions: Premature mortality from cancer and CVD imposes substantial and unequal productivity losses across Europe. Increasing investment in prevention and early detection, particularly in higher-burden Central and Eastern European countries, could reduce avoidable working-age mortality and support workforce sustainability and long-term economic resilience.